Schedule Dispatches
Schedule dispatches give a summary of changes coming out in the next month.
This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.
The full Update is available as a PDF(external link)
The changes will be published in the online Schedule around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz
June 2026
New Listings
- Colestyramine (Questran Light (Neon)) powder for oral suspension 4 g sachet – s29 and wastage claimable (p’code 2700026)
- Droperidol (Droperidol Panpharma) inj 2.5 mg per ml, 1 ml ampoule – subsidy by endorsement, up to 10 inj available on a PSO and only on a PSO (p’code 2527138)
- Efavirenz with emtricitabine and tenofovir disoproxil (TEEVIR (India)) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a fumarate) – Special Authority – Retail pharmacy – s29 and wastage claimable (p’code 2727994)
- Ezetimibe with simvastatin (Vytorin) tab 10 mg with simvastatin 80 mg – s29 and wastage claimable (p’code 2727730)
- Oestradiol valerate (Progynova) tab 2 mg (p’code 2730979)
- Paracetamol (Noumed) oral liq 120 mg per 5 ml, 200 ml – maximum of 600 ml per prescription; can be waived by endorsement, up to 200 ml available on a PSO, not in combination and access criteria apply (p’code 2721376)
- Ramipril (Ramipril Viatris) tab 2.5 mg – s29 and wastage claimable (p’code 2728184)
- Ribociclib (Kisqali) tab 200 mg, 21 tab pack (p’code 2728133), 42 tab pack (p’code 2728141) and 63 tab pack (p’code 2728168) – Special Authority – Retail pharmacy – Wastage claimable
- Risperidone (Risperidone Sandoz) tab 0.5 mg (p’code 2693143) and tab 2 mg (p’code 2693178) – Safety medicine; prescriber may determine dispensing frequency, s29 and wastage claimable
- Rizatriptan (Rizatriptan Viatris) tab orodispersible 10 mg – s29 and wastage claimable (p’code 2728311)
- Trimethoprim with sulphamethoxazole [Co-trimoxazole] (Deprim) oral liq 8 mg sulphamethoxazole 40 mg per ml, 200 ml – up to 200 ml available on a PSO (p’code 2730847)
Changes to restrictions, chemical names and presentations
- Chloramphenicol eye oint 1%, 5 g OP (Devatis) and eye drops 0.5%, 10 ml OP (Chlorafast) – addition of note
- Compound electrolytes (Electral) powder for oral soln – addition of note
- Compound electrolytes with glucose [Dextrose] soln with electrolytes, 1 OP (Hydralyte – Lemonade) and soln with electrolytes (2 × 500 ml), 1 OP (Pedialyte) – addition of note
- Dimethicone (healthE Dimethicone 4% Lotion) lotn 4%, 200 ml OP – addition of note
- Elexacaftor with tezacaftor, ivacaftor and ivacaftor (Trikafta) – amended Special Authority criteria
- Tab elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (56) and ivacaftor 150 mg (28), 84 OP
- Tab elexacaftor 50 mg with tezacaftor 25 mg, ivacaftor 37.5 mg (56) and ivacaftor 75 mg (28), 84 OP
- Oral granules elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (28) and ivacaftor 75 mg (28), sachets, 56 OP
- Oral granules elexacaftor 80 mg with tezacaftor 40 mg, ivacaftor 60 mg (28) and ivacaftor 59.5mg (28), sachets, 56 OP
- Furosemide [Frusemide] (IPCA-Frusemide) tab 40 mg – reinstate stat dispensing
- Ibuprofen (Ethics) oral liq 20 mg per ml, 200 ml – addition of note
- Insulin pump infusion set (steel cannula, straight insertion) (TruSteel) 6 mm steel cannula; straight insertion; 80 cm line × 10 with 10 needles, 8 mm steel cannula; straight insertion; 80 cm line × 10 with 10 needles, 6 mm steel cannula; straight insertion; 60 cm line × 10 with 10 needles and 8 mm steel cannula; straight insertion; 60 cm line × 10 with 10 needles – removal of stat dispensing
- Ivacaftor (Kalydeco) tab 150 mg and oral granules 13.4 mg, 25 mg, 50 mg and 75 mg, sachet – amended Special Authority criteria
- Montelukast (Montelukast Paediatric (Relonchem)) tab 5 mg – amended brand name
- Naproxen (Inza) tab 250 mg and 500 mg – removal of s29 and wastage claimable
- Nitrofurantoin (Macrobid) cap modified-release 100 mg – addition of note
- Paracetamol tab 500 mg – blister pack (Pacimol), oral liq 120mg per 5 ml, 200 ml (Paracetamol (Ethics) and Noumed) and oral liq 250 mg per 5 ml, 200 ml (Pamol) – addition of note
- Permethrin (A-Scabies) lotn 5%, 30 ml OP – addition of note
- Trimethoprim (TMP) tab 300 mg – addition of note
- Vanzacaftor with tezacaftor and deutivacaftor (Alyftrek) tab vanzacaftor 4 mg with tezacaftor 20 mg and deutivacaftor 50 mg, 84 OP and tab vanzacaftor 10 mg with tezacaftor 50 mg and deutivacaftor 125 mg, 56 OP – amended Special Authority criteria
- Venetoclax (Venclexta) tab 14 × 10 mg, 7 × 50 mg, 21 × 100 mg, 42 OP, tab 10 mg, 2 OP, tab 50 mg, 7 OP and tab 100 mg – amended Special Authority criteria
Increased subsidy
|
Chemical |
Presentation |
Fully subsidised brands |
|---|---|---|
|
Beta-HCG low sensitivity urine test kit |
Midstream, 1 test OP |
CheckTop |
|
Cyclizine lactate |
Inj 50 mg per ml, 1 ml ampoule |
Hameln |
|
Mifepristone |
Tab 200 mg, 1 and 3 tab pack |
Mifegyne |
|
Primaquine |
Tab 15 mg |
Sanofi Primaquine |
|
Water |
Inj 10 ml ampoule |
Multichem |